Correction: Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives

Seyed Saeed Tamehri Zadeh, Peter P. Toth, Maciej Banach

Open source

DOI
10.3389/fphar.2026.1943610
Published
2026-07-28
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1943610,
  title = {Correction: Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives},
  author = {Seyed Saeed Tamehri Zadeh and Peter P. Toth and Maciej Banach},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1943610},
  url = {https://doi.org/10.3389/fphar.2026.1943610}
}

RIS

TY  - JOUR
TI  - Correction: Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives
AU  - Seyed Saeed Tamehri Zadeh
AU  - Peter P. Toth
AU  - Maciej Banach
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1943610
UR  - https://doi.org/10.3389/fphar.2026.1943610
ER  - 

APA

Zadeh, S. S. T., Toth, P. P., & Banach, M. (2026). Correction: Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1943610

Source records